Relay Therapeutics, Inc. short interest in 2023
In 2023, Relay Therapeutics, Inc.'s disclosed short interest ran from 15.43% of shares outstanding on 13 Jan 2023 to 9.74% on 29 Dec 2023, a change of -5.69 percentage points. The year's high was 17.66% on 15 May 2023 and its low 9.74% on 29 Dec 2023, averaging 14.86% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 28.38 days on 31 Aug 2023. Full history: Relay Therapeutics, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2023 in figures
- Start of year
- 15.43% (13 Jan 2023)
- End of year
- 9.74% (29 Dec 2023)
- Change
- -5.69 pp
- High
- 17.66% (15 May 2023)
- Low
- 9.74% (29 Dec 2023)
- Average
- 14.86%
- Highest days to cover
- 28.38 (31 Aug 2023)
- SEC filings marked
- 8
Every report in 2023
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 13 Jan 2023 | 15.43% | 8.37 | |
| 31 Jan 2023 | 14.38% | 13.47 | |
| 15 Feb 2023 | 14.28% | 16.78 | |
| 28 Feb 2023 | 14.71% | 18.15 | 10-K filed, results (8-K) |
| 15 Mar 2023 | 14.83% | 16.81 | |
| 31 Mar 2023 | 15.64% | 18.12 | |
| 14 Apr 2023 | 16.16% | 12.65 | |
| 28 Apr 2023 | 16.28% | 5.99 | |
| 15 May 2023 | 17.66% | 14.40 | 10-Q filed, results (8-K) |
| 31 May 2023 | 17.40% | 15.45 | |
| 15 Jun 2023 | 17.34% | 17.88 | |
| 30 Jun 2023 | 16.84% | 12.50 | |
| 14 Jul 2023 | 16.32% | 20.98 | |
| 31 Jul 2023 | 16.14% | 22.49 | |
| 15 Aug 2023 | 16.95% | 22.78 | 10-Q filed, results (8-K) |
| 31 Aug 2023 | 16.28% | 28.38 | |
| 15 Sep 2023 | 16.44% | 14.92 | |
| 29 Sep 2023 | 15.88% | 20.01 | |
| 13 Oct 2023 | 11.28% | 10.27 | |
| 31 Oct 2023 | 11.70% | 11.46 | |
| 15 Nov 2023 | 11.88% | 11.62 | 10-Q filed, results (8-K) |
| 30 Nov 2023 | 11.87% | 16.49 | |
| 15 Dec 2023 | 11.11% | 10.04 | |
| 29 Dec 2023 | 9.74% | 13.83 |
See also: Relay Therapeutics, Inc.'s full history · most shorted US stocks of 2023 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.